One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-126286
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 24 |
Affiliation: Cornell University, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, University of California, San Diego, University of California, Irvine, Willamette Valley Cancer Institute and Research Center, Fred Hutch Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Dana-Farber Cancer Institute, Sunesis (United States)Ongoing Results of a Phase 1B/2 Dose-Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible Bruton'S Tyrosine Kinase Inhibitor, Vecabrutinib, in B-Cell Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
